| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Scientific Officer
1 company
Lorrain Daniel S. is a Chief Scientific Officer at Contineum Therapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 10 sells.
Estimated insider holdings value: $2.1M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 1, 2026 | CTNM Contineum Therapeutics, Inc. | Chief Scientific Officer | Sell | 4,170 | $13.12 | $54,694.20 | -1.4% | - | - | |
| Feb 3, 2026 | CTNM Contineum Therapeutics, Inc. | Chief Scientific Officer | Sell | 4,170 | $14.94 | $62,305.47 | -1.3% | -13.2% | - | |
| Jan 5, 2026 | CTNM Contineum Therapeutics, Inc. | Chief Scientific Officer | Sell | 4,170 | $10.44 | $43,543.16 | -1.3% | +34.4% | - | |
| Dec 23, 2025 | CTNM Contineum Therapeutics, Inc. | Chief Scientific Officer | Sell | 4,170 | $12.23 | $51,009.11 | -2.5% | +0.9% | - | |
| Nov 25, 2024 | CTNM Contineum Therapeutics, Inc. | Chief Scientific Officer | Sell | 1,010 | $16.02 | $16,177.37 | -0.6% | -50.6% | -30.3% | |
| Nov 18, 2024 | CTNM Contineum Therapeutics, Inc. | Chief Scientific Officer | Sell | 6,190 | $16.38 | $101,420.77 | -1.8% | -53.5% | -27.3% |